| Sep 16 |
Galapagos receives transparency notification from EcoR1 Capital
|
| Sep 1 |
Even after rising 13% this past week, Galapagos (AMS:GLPG) shareholders are still down 82% over the past five years
|
| Aug 28 |
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
|
| Aug 27 |
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
|
| Aug 26 |
Galapagos up 10% as major shareholder intends to talk about strategy
|
| Aug 26 |
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
|
| Aug 23 |
Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond
|
| Aug 23 |
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
|
| Aug 23 |
Galapagos gains after FDA nod for lymphoma trial
|
| Aug 23 |
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
|
